Yahoo Finance14m
Aelis Farma Announces the Positive Results of Its Clinical Phase 1/2 Study with AEF0217 in Young Adults With Down Syndrome
The CB 1-SSi AEF0217 successfully met the safety (primary), pharmacokinetic (secondary) and efficacy (secondary and ...
Down's syndrome cafe facing closure due to deficit
A charity that supports children and young people with Down's syndrome is facing a £30,000 deficit. Sunshine and Smiles may ...